RAvVA:Phase I/II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in Combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy

Project Details

Short titleRAvVA:Phase I/II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in Combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy
StatusFinished
Effective start/end date10/07/1231/12/22

Funding

  • CELGENE INTERNATIONAL SARL